Paradigm Biopharmaceuticals Limited

ASX (AUD): Paradigm Biopharmaceuticals Limited (PAR)

Last Price

0.445

Today's Change

-0.025 (5.31%)

Day's Change

0.435 - 0.465

Trading Volume

3,259,818

Profile
PAR

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC

Full Time Employees:  0 0

IPO Date:  2015-08-19 2015-08-19

CIK: 

ISIN:  AU000000PAR5 AU000000PAR5

CUSIP:  Q7269W102 Q7269W102

Beta:  0.87 0.87

Last Dividend:  0.00 0.00

Dcf Diff:  0.39 0.39

Dcf:  0.05 0.05

Description

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

Address

500 Collins Street,
Melbourne, VIC 3000, AU

61 3 9629 5566

http://www.paradigmbiopharma.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment